{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T11:59:15Z","timestamp":1789905555591,"version":"4.0.1"},"publisher-location":"Cham","reference-count":55,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319341347","type":"print"},{"value":"9783319341361","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/7854_2016_444","type":"book-chapter","created":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T02:04:48Z","timestamp":1459389888000},"page":"265-277","source":"Crossref","is-referenced-by-count":17,"title":["The Use of Perinatal 6-Hydroxydopamine to Produce a Rodent Model of Lesch\u2013Nyhan Disease"],"prefix":"10.1007","author":[{"given":"Darin J.","family":"Knapp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George R.","family":"Breese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,1]]},"reference":[{"key":"444_CR1","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3171\/2014.8.PEDS1451","volume":"14","author":"TJ Abel","year":"2014","unstructured":"Abel TJ, Dalm BD, Grossbach AJ, Jackson AE, Thomsen T, Greenlee JD (2014) Lateralized effect of pallidal stimulation on self-mutilation in Lesch-Nyhan disease. J Neurosurg Pediatr 14:594\u2013597","journal-title":"J Neurosurg Pediatr"},{"key":"444_CR2","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/0278-5846(96)00059-0","volume":"20","author":"SM Allen","year":"1996","unstructured":"Allen SM, Rice SN (1996) Risperidone antagonism of self-mutilation in a Lesch-Nyhan patient. Prog Neuropsychopharmacol Biol Psychiatry 20:793\u2013800","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"444_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/BF02172213","volume":"24","author":"LT Anderson","year":"1994","unstructured":"Anderson LT, Ernst M (1994) Self-injury in Lesch-Nyhan disease. J Autism Dev Disord 24(1):67\u201381","journal-title":"J Autism Dev Disord"},{"key":"444_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1471-4159.1986.tb02837.x","volume":"47","author":"CM Bitler","year":"1986","unstructured":"Bitler CM, Howard BD (1986) Dopamine metabolism in hypoxanthine-guanine phosphoribosyltransferase-deficient variants of PC12 cells. J Neurochem 47:107\u2013112","journal-title":"J Neurochem"},{"issue":"3","key":"444_CR5","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S0091-3057(84)80110-0","volume":"21","author":"GR Breese","year":"1984","unstructured":"Breese GR, Baumeister AA, McCown TJ, Emerick SG, Frye GD, Mueller RA (1984) Neonatal-6-hydroxydopamine treatment: model of susceptibility for self-mutilation in the Lesch-Nyhan syndrome. Pharmacol Biochem Behav 21(3):459\u2013461","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"444_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.brainresrev.2004.08.004","volume":"48","author":"GR Breese","year":"2005","unstructured":"Breese GR, Knapp DJ, Criswell HE, Moy SS, Papadeas ST, Blake BL (2005) The neonate-6-hydroxydopamine-lesioned rat: a model for clinical neuroscience and neurobiological principles. Brain Res Rev 48(1):57\u201373","journal-title":"Brain Res Rev"},{"key":"444_CR54","doi-asserted-by":"crossref","unstructured":"Breese GR, Traylor TD (1970) Effect of 6-hydroxydopamine on brain norepinephrine and dopamine: evidence for selective degeneration of catecholamine neurons. J Pharmacol Exp Ther 174:413\u2013420","DOI":"10.1016\/S0022-3565(25)28637-2"},{"issue":"2","key":"444_CR55","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1476-5381.1972.tb07257.x","volume":"44","author":"G. R. BREESE","year":"1972","unstructured":"Breese GR, Traylor TD (1972) Developmental characteristics of brain catecholamines and tyrosine hydroxylase in the rat: effects of 6-hydroxydopamine. Br J Pharmcol 44:210\u2013222","journal-title":"British Journal of Pharmacology"},{"key":"444_CR7","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ymgme.2013.08.016","volume":"110","author":"I Ceballos-Picot","year":"2013","unstructured":"Ceballos-Picot I, Auge F, Fu R, Olivier-Bandini A, Cahu J, Chabrol B, Aral B, de Martinville B, Lecain JP, Jinnah HA (2013) Phenotypic variation among seven members of one family with deficiency of hypoxanthine-guanine phosphoribosyltransferase. Mol Genet Metab 110:268\u2013274","journal-title":"Mol Genet Metab"},{"issue":"4","key":"444_CR8","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.ymgme.2015.02.007","volume":"114","author":"EB Dammer","year":"2015","unstructured":"Dammer EB, G\u00f6ttle M, Duong DM, Hanfelt J, Seyfried NT, Jinnah HA (2015) Consequences of impaired purine recycling on the proteome in a cellular model of Lesch-Nyhan disease. Mol Genet Metab 114(4):570\u2013579","journal-title":"Mol Genet Metab"},{"issue":"4\u20136","key":"444_CR9","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1080\/15257770.2014.880477","volume":"33","author":"L Dauphinot","year":"2014","unstructured":"Dauphinot L, Mockel L, Cahu J, Jinnah HA, Ledroit M, Potier MC, Ceballos-Picot I (2014) Transcriptomic approach to Lesch-Nyhan disease. Nucleosides, Nucleotides Nucleic Acids 33(4\u20136):208\u2013217","journal-title":"Nucleosides, Nucleotides Nucleic Acids"},{"issue":"9","key":"444_CR10","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/nn.4091","volume":"18","author":"K Deisseroth","year":"2015","unstructured":"Deisseroth K (2015) Optogenetics: 10\u00a0years of microbial opsins in neuroscience. Nat Neurosci 18(9):1213\u20131225","journal-title":"Nat Neurosci"},{"key":"444_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/978-1-61779-458-2_4","volume":"829","author":"DP Devine","year":"2012","unstructured":"Devine DP (2012) Animal models of self-injurious behavior: an overview. Methods Mol Biol 829:65\u201384","journal-title":"Methods Mol Biol"},{"key":"444_CR12","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1093\/hmg\/5.10.1607","volume":"5","author":"SJ Engle","year":"1996","unstructured":"Engle SJ, Womer DE, Davies PM, Boivin G, Sahota A, Simmonds HA, Stambrook PJ, Tischfield JA (1996) HPRT-APRT-deficient mice are not a model for Lesch-Nyhan syndrome. Hum Mol Genet 5:1607\u20131610","journal-title":"Hum Mol Genet"},{"issue":"24","key":"444_CR13","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1056\/NEJM199606133342403","volume":"334","author":"M Ernst","year":"1996","unstructured":"Ernst M, Zametkin AJ, Matochik JA, Pascualvaca D, Jons PH, Hardy K, Hankerson JG, Doudet DJ, Cohen RM (1996) Presynaptic dopaminergic deficits in Lesch-Nyhan disease. N Engl J Med 334(24):1568\u20131572","journal-title":"N Engl J Med"},{"key":"444_CR14","doi-asserted-by":"crossref","unstructured":"Fu R, Ceballos-Picot I, Torres RJ, Larovere LE, Yamada Y, Nguyen KV, Hegde M, Visser JE, Schretlen DJ, Nyhan WL, Puig JG, O\u2019Neill PJ, Jinnah HA, Lesch-Nyhan Disease International Study Group (2014) Genotype-phenotype correlations in neurogenetics: Lesch-Nyhan disease as a model disorder. Brain 137:1282\u20131303","DOI":"10.1093\/brain\/awt202"},{"issue":"1","key":"444_CR15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/ana.24191","volume":"76","author":"M G\u00f6ttle","year":"2014","unstructured":"G\u00f6ttle M, Prudente CN, Fu R, Sutcliffe D, Pang H, Cooper D, Veledar E, Glass JD (2014) Loss of dopamine phenotype among midbrain neurons in Lesch-Nyhan disease. Ann Neurol 76(1):95\u2013107","journal-title":"Ann Neurol"},{"key":"444_CR16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/bs.adgen.2015.06.001","volume":"90","author":"GH Guibinga","year":"2015","unstructured":"Guibinga GH (2015) MicroRNAs: tools of mechanistic insights and biological therapeutics discovery for the rare neurogenetic syndrome Lesch-Nyhan disease (LND). Adv Genet 90:103\u2013131","journal-title":"Adv Genet"},{"key":"444_CR17","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/326292a0","volume":"326","author":"M Hooper","year":"1987","unstructured":"Hooper M, Hardy K, Handyside A, Hunter S, Monk M (1987) HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cells. Nature 326:292\u2013295","journal-title":"Nature"},{"issue":"1","key":"444_CR18","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1124\/jpet.109.159186","volume":"332","author":"MM Huang","year":"2010","unstructured":"Huang MM, Overstreet DH, Knapp DJ, Angel R, Wills TA, Navarro M, Rivier J, Vale W, Breese GR (2010) Corticotropin-releasing factor (CRF) sensitization of ethanol withdrawal-induced anxiety-like behavior is brain site specific and mediated by CRF-1 receptors: relation to stress-induced sensitization. J Pharmacol Exp Ther 332(1):298\u2013307","journal-title":"J Pharmacol Exp Ther"},{"key":"444_CR19","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1242\/dmm.002543","volume":"2","author":"HA Jinnah","year":"2009","unstructured":"Jinnah HA (2009) Lesch-Nyhan disease: from mechanism to model and back again. Dis Model Mech 2:116\u2013121","journal-title":"Dis Model Mech"},{"key":"444_CR20","first-page":"94","volume-title":"Biological aspects of disease: contributions from animcal models","author":"HA Jinnah","year":"1997","unstructured":"Jinnah HA, Breese GR (1997) Anmal models for Lesch-Nyhan disease. In: Iannocconne PM, Scarpelli DG (eds) Biological aspects of disease: contributions from animcal models. Harwood Academic Publishers, Amersterdam, pp 94\u2013143"},{"key":"444_CR21","first-page":"2537","volume-title":"The metabolic and molecular bases of inherited disease","author":"HA Jinnah","year":"2001","unstructured":"Jinnah HA, Friedmann T (2001) Lesch-Nyhan disease and its variants. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw Hill, New York, pp 2537\u20132570"},{"key":"444_CR22","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/1044-7431(92)90010-Y","volume":"3","author":"HA Jinnah","year":"1992","unstructured":"Jinnah HA, Hess EJ, Wilson MC, Gage FH, Friedmann T (1992) Localization of hypoxanthine-guanine phosphoribosyltransferase mRNA in the mouse brain by in situ hybridization. Mol Cell Neurosci 3:64\u201378","journal-title":"Mol Cell Neurosci"},{"key":"444_CR23","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1111\/j.1471-4159.1993.tb03488.x","volume":"60","author":"HA Jinnah","year":"1993","unstructured":"Jinnah HA, Page T, Friedmann T (1993) Brain purines in a genetic mouse model of Lesch-Nyhan disease. J Neurochem 60:2036\u20132045","journal-title":"J Neurochem"},{"key":"444_CR24","doi-asserted-by":"publisher","first-page":"15228","DOI":"10.1073\/pnas.96.26.15228","volume":"96","author":"HA Jinnah","year":"1999","unstructured":"Jinnah HA, Yitta S, Drew T, Kim BS, Visser JE, Rothstein JD (1999a) Calcium channel activation and self-biting in mice. Proc Nat Acad Sci USA 96:15228\u201315232","journal-title":"Proc Nat Acad Sci USA"},{"key":"444_CR25","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1046\/j.1471-4159.1999.0720225.x","volume":"72","author":"HA Jinnah","year":"1999","unstructured":"Jinnah HA, Jones MD, Wojcik BE, Rothstein JD, Hess EJ, Friedmann T, Breese GR (1999b) Influence of age and strain on striatal dopamine loss in a genetic mouse model of Lesch-Nyhan disease. J Neurochem 72:225\u2013229","journal-title":"J Neurochem"},{"key":"444_CR26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.neulet.2015.01.042","volume":"590","author":"TH Kang","year":"2015","unstructured":"Kang TH, Friedmann T (2015) Alzheimer\u2019s disease shares gene expression aberrations with purinergic dysregulation of HPRT deficiency (Lesch-Nyhan disease). Neurosci Lett 590:35\u201339","journal-title":"Neurosci Lett"},{"issue":"10","key":"444_CR27","doi-asserted-by":"publisher","first-page":"e74967","DOI":"10.1371\/journal.pone.0074967","volume":"8","author":"TH Kang","year":"2013","unstructured":"Kang TH, Park Y, Bader JS, Friedmann T (2013) The housekeeping gene hypoxanthine guanine phosphoribosyltransferase (HPRT) regulates multiple developmental and metabolic pathways of murine embryonic stem cell neuronal differentiation. PLoS ONE 8(10):e74967","journal-title":"PLoS ONE"},{"issue":"11","key":"444_CR28","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1111\/j.1530-0277.2007.00514.x","volume":"31","author":"DJ Knapp","year":"2007","unstructured":"Knapp DJ, Overstreet DH, Angel RA, Navarro M, Breese GR (2007) The amygdala regulates the antianxiety sensitization effect of flumazenil during repeated chronic ethanol or repeated stress. Alcohol Clin Exp Res 31(11):1872\u20131882","journal-title":"Alcohol Clin Exp Res"},{"issue":"Suppl 1","key":"444_CR29","doi-asserted-by":"publisher","first-page":"S146","DOI":"10.1016\/j.bbi.2011.02.018","volume":"25","author":"DJ Knapp","year":"2011","unstructured":"Knapp DJ, Whitman BA, Wills TA, Angel RA, Overstreet DH, Criswell HE, Ming Z, Breese GR (2011a) Cytokine involvement in stress may depend on corticotrophin releasing factor to sensitize ethanol withdrawal anxiety. Brain Behav Immun 25(Suppl 1):S146\u2013S154","journal-title":"Brain Behav Immun"},{"issue":"1","key":"444_CR30","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00213-011-2366-5","volume":"218","author":"DJ Knapp","year":"2011","unstructured":"Knapp DJ, Overstreet DH, Huang M, Wills TA, Whitman BA, Angel RA, Sinnett SE, Breese GR (2011b) Effects of a stressor and corticotrophin releasing factor on ethanol deprivation-induced ethanol intake and anxiety-like behavior in alcohol-preferring P rats. Psychopharmacology 218(1):179\u2013189","journal-title":"Psychopharmacology"},{"key":"444_CR31","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/326295a0","volume":"326","author":"MR Kuehn","year":"1987","unstructured":"Kuehn MR, Bradley A, Robertson EJ, Evans MJ (1987) A potential animal model for Lesch-Nyhan syndrome through introduction of HPRT mutations into mice. Nature 326:295\u2013298","journal-title":"Nature"},{"issue":"4","key":"444_CR32","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.drudis.2013.10.018","volume":"19","author":"HM Lee","year":"2014","unstructured":"Lee HM, Giguere PM, Roth BL (2014) DREADDs: novel tools for drug discovery and development. Drug Discov Today 19(4):469\u2013473","journal-title":"Drug Discov Today"},{"key":"444_CR33","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.neuroscience.2007.10.065","volume":"152","author":"JC Lewers","year":"2008","unstructured":"Lewers JC, Ceballos-Picot I, Shirley TL, Mockel L, Egami K, Jinnah HA (2008) Consequences of impaired purine recycling in dopaminergic neurons. Neuroscience 152:761\u2013772","journal-title":"Neuroscience"},{"issue":"19","key":"444_CR34","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1056\/NEJM198111053051902","volume":"305","author":"KG Lloyd","year":"1981","unstructured":"Lloyd KG, Hornykiewicz O, Davidson L, Shannak K, Farley I, Goldstein M, Shibuya M, Kelley WN, Fox IH (1981) Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome. N Engl J Med 305(19):1106\u20131111","journal-title":"N Engl J Med"},{"issue":"5","key":"444_CR35","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/j.1365-2788.2011.01485.x","volume":"56","author":"AM Muehlmann","year":"2012","unstructured":"Muehlmann AM, Kies SD, Turner CA, Wolfman S, Lewis MH, Devine DPM (2012) Self-injurious behaviour: limbic dysregulation and stress effects in an animal model. J Intellect Disabil Res 56(5):490\u2013500","journal-title":"J Intellect Disabil Res"},{"key":"444_CR36","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3389\/fnmol.2014.00076","volume":"7","author":"G Murlidharan","year":"2014","unstructured":"Murlidharan G, Samulski RJ, Asokan A (2014) Biology of adeno-associated viral vectors in the central nervous system. Front Mol Neurosci 7:76","journal-title":"Front Mol Neurosci"},{"issue":"10","key":"444_CR37","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1080\/15257770.2015.1071844","volume":"34","author":"KV Nguyen","year":"2015","unstructured":"Nguyen KV (2015) Epigenetic regulation in amyloid precursor protein with genomic rearrangements and the Lesch-Nyhan syndrome. Nucleosides, Nucleotides Nucleic Acids 34(10):674\u2013690","journal-title":"Nucleosides, Nucleotides Nucleic Acids"},{"key":"444_CR38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/978-1-4614-5836-4_59","volume-title":"Handbook of neurotoxicity","author":"ST Papadeas","year":"2014","unstructured":"Papadeas ST, Breese GR (2014) 6-Hydroxydopamine lesioning of dopamine neurons in neonatal and adult rats induces age-dependent consequences. In: Kostrzewa RM (ed) Handbook of neurotoxicity. Springer, New York, pp 133\u2013198"},{"key":"444_CR39","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/ner.12261","volume":"18","author":"F Piedimonte","year":"2015","unstructured":"Piedimonte F, Andreani JC, Piedimonte L, Micheli F, Graff P, Bacaro V (2015) Remarkable clinical improvement with bilateral globus pallidus internus deep brain stimulation in a case of Lesch-Nyhan disease: five-year follow-up. Neuromodulation 18:118\u2013122","journal-title":"Neuromodulation"},{"key":"444_CR40","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s13023-014-0208-3","volume":"9","author":"M Pozzi","year":"2014","unstructured":"Pozzi M, Piccinini L, Gallo M, Motta F, Radice S, Clementi E (2014) Treatment of motor and behavioural symptoms in three Lesch-Nyhan patients with intrathecal baclofen. Orphanet J Rare Dis 9:208","journal-title":"Orphanet J Rare Dis"},{"key":"444_CR41","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1055\/s-2007-973462","volume":"30","author":"Y Saito","year":"1999","unstructured":"Saito Y, Ito M, Hanaoka S, Ohama E, Akaboshi S, Takashima S (1999) Dopamine receptor upregulation in Lesch-Nyhan syndrome: a postmortem study. Neuropediatrics 30:66\u201371","journal-title":"Neuropediatrics"},{"key":"444_CR42","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/S1474-4422(13)70238-2","volume":"12","author":"FJ Schretlen","year":"2013","unstructured":"Schretlen FJ, Varvaria M, Te Ho, Vannorsdall TD, Gordon B, Harris JC, Jinnah HA (2013) Regional brain volume abnormalities in Lesch-Nyhan disease and its variants: a cross-sectional study. Lancet Neurol 12:1151\u20131158","journal-title":"Lancet Neurol"},{"key":"444_CR43","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1212\/WNL.0000000000001128","volume":"84","author":"DJ Schretlen","year":"2015","unstructured":"Schretlen DJ, Varvaris M, Vannorsdall TD, Gordon B, Harris JC, Jinnah HA (2015) Brain white matter volume abnormalities in Lesch-Nyhan disease and its variants. Neurology 84:190\u2013196","journal-title":"Neurology"},{"key":"444_CR44","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1111\/j.1471-4159.2007.04472.x","volume":"101","author":"TL Shirley","year":"2007","unstructured":"Shirley TL, Lewers JC, Egami K, Majumdar A, Kelly M, Ceballos-Picot I, Seidman MM, Jinnah HA (2007) A human neuronal tissue culture model for Lesch-Nyhan disease. J Neurochem 101:841\u2013853","journal-title":"J Neurochem"},{"issue":"1","key":"444_CR45","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/S0006-8993(97)01128-1","volume":"783","author":"CJ Stodgell","year":"1998","unstructured":"Stodgell CJ, Loupe PS, Schroeder SR, Tessel RE (1998) Cross-sensitization between footshock stress and apomorphine on self-injurious behavior and neostriatal catecholamines in a rat model of Lesch-Nyhan syndrome. Brain Res 783(1):10\u201318","journal-title":"Brain Res"},{"issue":"5","key":"444_CR46","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.tins.2007.03.008","volume":"30","author":"DJ Surmeier","year":"2007","unstructured":"Surmeier DJ, Ding J, Day M, Wang Z, Shen W (2007) D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends Neurosci 30(5):228\u2013235","journal-title":"Trends Neurosci"},{"key":"444_CR47","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s10545-015-9854-4","volume":"38","author":"RJ Torres","year":"2015","unstructured":"Torres RJ, Puig JG (2015) Hypoxanthine deregulates genes involved in early neuronal development: implications in Lesch-Nyhan disease pathogenesis. J Inherit Metab Dis 38:1109\u20131118","journal-title":"J Inherit Metab Dis"},{"key":"444_CR48","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.rce.2014.03.018","volume":"214","author":"M Trigueros Genao","year":"2014","unstructured":"Trigueros Genao M, Torres RJ (2014) From genotype to phenotype; clinical variability in Lesch-Nyhan disease. The role of epigenetics. Rev Clin Esp 214:461\u2013465","journal-title":"Rev Clin Esp"},{"key":"444_CR49","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.neulet.2015.10.011","volume":"609","author":"SK Tschirner","year":"2015","unstructured":"Tschirner SK, Gutzki F, Kaever V, Seifert R, Schneider EH (2015) Altered histamine neurotransmission in HPRT-deficient mice. Neurosci Lett 609:74\u201380","journal-title":"Neurosci Lett"},{"key":"444_CR50","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1146\/annurev-pharmtox-010814-124803","volume":"55","author":"DJ Urban","year":"2015","unstructured":"Urban DJ, Roth B (2015) DREADDs (designer receptors exclusively activated by designer drugs): chemogenetic tools with therapeutic utility. Annu Rev Pharmacol Toxicol 55:399\u2013417","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"444_CR51","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.neuropharm.2012.03.004","volume":"69","author":"MS Weinberg","year":"2013","unstructured":"Weinberg MS, Samulski RJ, McCown TJ (2013) Adeno-associated virus (AAV) gene therapy for neurological disease. Neuropharmacology 69:82\u201388","journal-title":"Neuropharmacology"},{"key":"444_CR52","doi-asserted-by":"publisher","first-page":"5539","DOI":"10.1073\/pnas.93.11.5539","volume":"93","author":"DF Wong","year":"1996","unstructured":"Wong DF, Harris JC, Naidu S, Yokoi F, Marenco S, Dannals RF, Ravert HT, Yaster M, Evans A, Rousset O et al (1996) Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo. Proc Nat Acad Sci USA 93:5539\u20135543","journal-title":"Proc Nat Acad Sci USA"},{"key":"444_CR53","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/(SICI)1097-4547(19980701)53:1<78::AID-JNR8>3.0.CO;2-G","volume":"53","author":"J Yeh","year":"1998","unstructured":"Yeh J, Zheng S, Howard BD (1998) Impaired differentiation of HPRT-deficient dopaminergic neurons: a possible mechanism underlying neuronal dysfunction in Lesch-Nyhan syndrome. J Neurosci Res 53:78\u201385","journal-title":"J Neurosci Res"}],"container-title":["Current Topics in Behavioral Neurosciences","Neurotoxin Modeling of Brain Disorders\u2014Life-long Outcomes in Behavioral Teratology"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/7854_2016_444","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T01:39:35Z","timestamp":1748828375000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/7854_2016_444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9783319341347","9783319341361"],"references-count":55,"URL":"https:\/\/doi.org\/10.1007\/7854_2016_444","relation":{},"ISSN":["1866-3370","1866-3389"],"issn-type":[{"value":"1866-3370","type":"print"},{"value":"1866-3389","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}